Virtual Education Program to Support Black Female Patients with Stages I, II, and III Breast Cancer

This clinical trial evaluates the effect of a breast cancer survivor education program on black female patients with stage I-III breast cancer. Five to 10 years after diagnosis is an important time period in survivorship. The number of black breast cancer survivors is increasing but they are less likely to carry out recommended follow up during this time period. Education programs focusing on the needs of black breast cancer survivors may be an effective method to help them learn more about survivorship. This may lower their risk of recurrence and increase their quality of life.

Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05700396.

Trial PhaseNo phase specified

Trial Typesupportive care

Lead OrganizationDana-Farber Harvard Cancer Center

Principal InvestigatorErica T. Warner

• Primary ID22-509
• Secondary IDsNCI-2023-00788
• ClinicalTrials.gov IDNCT05700396